Riskpilot← Back to searchSign inGet full accessOncodia AB
ABActiveOrg 5591451819Knivstagatan 8Computer programming activities · NACE 6210Est. 20182 employees
Revenue 2024
SEK 456K
+19% vs 2023
EBITDA margin
-822.8%
+34% vs 2023
Equity ratio
83.7%
Financial strength
Net profit 2024
SEK -3,9M
+33% vs 2023
| Revenue | SEK 456K | +19% |
| EBITDA | SEK -3,8M | +34% |
| Net profit | SEK -3,9M | +33% |
| Total assets | SEK 4,1M | -46% |
| Equity | SEK 3,5M | -27% |
| Employees | 2 | — |
Legal name
Oncodia AB
Org number
5591451819
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
15 januari 2018
Share capital
SEK 205 779
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder Styrelsen ska bestå av 5 styrelseledamöter och 1 styrelsesuppleant.
Company purpose
Bolaget ska bedriva verksamhet bestående i att utveckla och producera hårdvara och mjukvara för analys av mutationer i gensekvenser, tillhandahålla tjänster för analys av mutationer i gensekvenser samt därmed förenlig verksamhet.
Address
Knivstagatan 8
Email
info@oncodia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 18 | 453 | 307 | 266 | 384 | 456 |
| Staff expenses | — | — | — | — | — | −1 957 | −746 |
| EBITDA | −114 | −1 174 | −2 387 | −4 632 | −6 539 | −5 699 | −3 754 |
| Depreciation & amort. | −0 | −42 | −138 | −138 | −138 | −177 | −176 |
| EBIT | −114 | −1 216 | −2 525 | −4 770 | −6 677 | −5 876 | −3 930 |
| Net financials | — | −14 | — | — | — | −18 | 2 |
| Profit before tax | −114 | −1 230 | −2 525 | −4 770 | −6 677 | −5 894 | −3 928 |
| Tax | −0 | −0 | −0 | −0 | −0 | — | — |
| Net profit | −114 | −1 230 | −2 525 | −4 770 | −6 677 | −5 894 | −3 928 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 343 | 3 537 | 4 031 | 3 129 | 6 882 | 7 693 | 4 130 |
| Equity | 11 | 2 715 | 3 501 | 2 183 | 3 977 | 4 739 | 3 456 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | — | — |
| Short-term debt | 332 | 821 | 530 | 946 | 2 906 | 2 954 | 674 |
| Total debt | 332 | 821 | 530 | 946 | 2 906 | 2 954 | 674 |
EBITDA margin
-822.8%
This company
15.8%
Market median
-5308% vs market
20182024
Equity ratio
83.7%
This company
38.2%
Market median
+119% vs market
20182024
Return on equity
-113.6%
This company
18.4%
Market median
-717% vs market
20182024
Net profit margin
-861.0%
This company
8.1%
Market median
-10730% vs market
20182024
Asset turnover
0.11×
This company
1.12×
Market median
-90% vs market
20182024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20182024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OK Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
IV Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
KJ Chief Auditor | Chief Auditor | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oncodia AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Odd Kristofer Maad | Chief Executive Officer | 0 companies |
| Ivaylo Valentinov Stoimenov | Chief Executive Officer | 0 companies |
| Karl Johan Herman Mattsson | Chief Auditor | 0 companies |
| Jon Daniel Bergström | Board of Directors | 0 companies |
| Luis Mateo Santurio Puentes | Board of Directors | 0 companies |
| Ian Cheong | Board of Directors | 0 companies |
| Nils Henrik Didner | Board of Directors | 0 companies |
| Jonas Erik Anders Hedlund | Chairman | 0 companies |
| Karl Fredrik Ludvig Paulsson | Board of Directors | 0 companies |
| Carl Tobias Sjöblom | Board of Directors | 0 companies |
| Karl Viktor Georg Ljungström | Deputy Board Member | 0 companies |
| Kerstin Maria C Åkesson Jakobsson | Board of Directors | 0 companies |
| Henrik Johannes Magnusson Hjorth | Board of Directors | 0 companies |